Estimated reading time: 5 minutes
Table of contents
Introduction
South Carolina’s opportunity to legalize medical cannabis is back on the legislative table in 2025. Lawmakers are revisiting reform efforts with a renewed focus on establishing a tightly regulated market that aligns with the state’s conservative approach to cannabis policy.
Legislative History and Current Proposal
State Sen. Tom Davis, R-Beaufort, reintroduced the Compassionate Care Act in January with Senate Bill 53. The proposed legislation aims to create a licensed and regulated market where qualifying patients can purchase lab-tested cannabis dispensed by pharmacists. Under this framework, patients would need to maintain closely defined relationships with their physicians to receive a diagnosis for one of the 12 qualifying conditions outlined in the bill. Additionally, the bill explicitly prohibits both smoking cannabis and growing it at home.
Davis, cosponsoring the bill with Sen. Stephen Goldfinch, R-Georgetown, has been a long-time advocate for cannabis reform in South Carolina. He previously sponsored similar versions of the Compassionate Care Act. In February 2024, a Senate-passed version of the bill received a 24-19 vote, but the proposal ultimately stalled in the House committee process due to inaction.
Challenges and Conservative Approach
The current version of the Compassionate Care Act reflects a very conservative approach to cannabis legalization—one that Davis insists is what South Carolinians want. “It is a very conservative bill because that’s what South Carolinians want,” Davis told WSPA. This cautious stance aims to address concerns by tightly controlling patient eligibility and strictly limiting consumption methods.
Davis’s earlier attempt in 2022 encountered a procedural setback when a Senate-passed version of the bill, which included a tax provision, was derailed. Under South Carolina law, revenue-raising bills must originate in the lower chamber, leading to the collapse of that version. This history of House lawmakers blocking reform efforts has left South Carolina with a “maybe” forecast for 2025. Notably, the state remains one of only eight without a medical cannabis program—even when compared to highly restrictive models like Texas’s, where THC is capped at 1%.
Conclusion
As South Carolina heads into the 2025 legislative session, the future of medical cannabis legalization remains uncertain. With the reintroduction of the Compassionate Care Act, advocates hope that a carefully tailored, conservative approach will finally break the legislative impasse. However, the history of procedural obstacles and House inaction continues to cast doubt on whether reform will ultimately prevail in the Palmetto State.
Cannabis Legalization South Carolina 2025 FAQs
There are no dispensaries in South Carolina due to the state’s prohibition of cannabis. Generally, dispensaries in legal states do not accept medical insurance for weed purchases.
CBD oil is legal for both medical and recreational use in South Carolina, although it can’t be sold as a food product. There are no legal age limits for purchasing CBD, so you can expect retailers to set age requirements at their own discretion. Most will require buyers to be over the age of 18 or 21.
Marijuana is illegal in South Carolina and cannot be delivered to residents.
Yes, Farm Bill compliant Delta 9 gummies are legal in South Carolina. You can buy Delta 9 gummies online or in-store without any restrictions, so long as they meet the following conditions: The THC must be derived from the hemp plant rather than the marijuana plant. THC concentrations must not exceed 0.3% by dry weight.
Possession of marijuana in South Carolina is classified as a misdemeanor in most cases. If you are convicted of possession of marijuana (less than one ounce), the penalty for the first offense is a $650 fine and up to 30 days in jail.
Qualifying for the medical marijuana program in South Carolina is simple. Patience must have a qualifying condition and a written certification issued by a doctor that has completed a full assessment of the patient’s medical history and current medical conditions.
Marijuana is illegal for recreational and medical purposes in South Carolina, and the use of CBD oil is only permitted for qualifying patients suffering from chronic seizures caused by epilepsy.
Additional Resources
Free eBooks For Cannabis Business Success
Latest Articles
- Navigating the Minnesota Social Equity and Cannabis Licensing Landscape: 2026 Comprehensive Strategic Analysis
As of April 15, 2026, the landscape is defined by the full enforcement of permanent licensure requirements. The landmark hard transition deadline of March 31, 2026, forced all temporary registrations for Lower-Potency Hemp Edible (LPHE) manufacturers and wholesalers to convert into full OCM licenses or face immediate operational shutdown. - The Minnesota Cannabis Microbusiness Regulatory Framework: A Strategic Analysis for the 2026 Licensure Cycle
The landscape of the Minnesota cannabis industry in April 2026 represents a mature, high-stakes regulatory environment that has moved decisively beyond the initial implementation phase characterized by the 2023 legislative session and the 2025 lottery cycles. The state has entered what regulators and industry analysts term the “scale-up” phase, a period defined by rigorous enforcement, the end of temporary registrations for hemp-derived businesses, and a transition to “Pharma-Grade” operational standards. - Cannabis HVAC Design: The Psychrometrics of Profit and Operational Scalability in 2026
In 2026, the global cannabis market has moved into a “Pharma-Grade” era. As of 2026, the leading cultivators are no longer just managing “temperature and humidity.” They are managing Vapor Pressure Deficit (VPD) and Biogenic Volatile Organic Compounds (BVOCs) to maximize secondary metabolite production (terpenes and cannabinoids) while slashing carbon footprints. - The 2026 Strategic Play: Mastering the New York Adult-Use Processor Type 3 Branding License
In 2021, New York legalized. In 2025, it launched. In April 2026, the market is maturing at an unprecedented rate. The “green rush” of speculative applications has been replaced by a sophisticated “Branding Phase.” As of this month, the Office of Cannabis Management (OCM) has authorized over 532 processors, many of whom are actively seeking high-quality brand partners to fill their white-label capacity. - Don’t Get Left Behind: Securing Your New York Cannabis License in 2026
The era of “provisional waiting” is over. The Office of Cannabis Management (OCM) has now issued over 2,160 adult-use licenses statewide. For entrepreneurs, the message is clear: the market is live, the supply chain is scaling, and the opportunity for professional, compliant operators has never been greater. - Overcoming the Complexities of Minnesota Cannabis Licensing in 2026: Navigating the Scale-Up Phase
In 2026, Minnesota’s cannabis market has transitioned from initial launch to a high-stakes scale-up phase. To succeed, applicants must move beyond basic requirements to demonstrate “pharma-grade” compliance, long-term financial stability, and total operational readiness. We have outlined the most critical hurdles currently facing 2026 applicants – from navigating the 65% social equity ownership audit to overcoming the statewide testing bottleneck.